Safety and Immune Responses to a DNA-Based Human Immunodeficiency Virus (HIV) Type I Env/Rev Vaccine in HIV-Infected Recipients: Follow-up Data

Saved in:
Bibliographic Details
Published inThe Journal of infectious diseases Vol. 181; no. 1; p. 406
Main Authors MacGregor, Rob Roy, Boyer, Jean D., Ciccarelli, Richard B., Ginsberg, Richard S., Weiner, David B.
Format Journal Article
LanguageEnglish
Published United States The University of Chicago Press 01.01.2000
University of Chicago Press
Subjects
AIDS Vaccines - immunology
AIDS Vaccines - therapeutic use
AIDS/HIV
Antibodies
Antiretrovirals
CD4 Lymphocyte Count
Cohort Studies
Correspondence
Dosage
Follow-Up Studies
Gene Products, env - genetics
Gene Products, env - immunology
Gene Products, env - therapeutic use
Gene Products, rev - genetics
Gene Products, rev - immunology
Gene Products, rev - therapeutic use
HIV
HIV 1
HIV Infections - drug therapy
Humans
Infections
Infectious diseases
Lymphocytes
rev Gene Products, Human Immunodeficiency Virus
Vaccination
Vaccines, DNA - immunology
Vaccines, DNA - therapeutic use
Viral load
Online AccessGet full text

Cover

More Information
Bibliography:istex:35C4382F8292898FACB14C55F098E6F610EF2061
ark:/67375/HXZ-1T438BG3-1
SourceType-Other Sources-1
ObjectType-Article-2
content type line 63
ObjectType-Commentary-4
ObjectType-Feature-1
ObjectType-Correspondence-3
ISSN:0022-1899
1537-6613
DOI:10.1086/315199